These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 26968522)
21. Spondylarthropathies in children--are they different from those in adults? Hofer M Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):315-28. PubMed ID: 16546059 [TBL] [Abstract][Full Text] [Related]
22. Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis. Srinivasalu H; Oliver M; Stoll ML; Weiss PF; Colbert RA; Clin Exp Rheumatol; 2022 Jul; 40(7):1442-1446. PubMed ID: 35485412 [TBL] [Abstract][Full Text] [Related]
23. Update on juvenile spondyloarthritis. Ramanathan A; Srinivasalu H; Colbert RA Rheum Dis Clin North Am; 2013 Nov; 39(4):767-88. PubMed ID: 24182854 [TBL] [Abstract][Full Text] [Related]
24. [Treatment outcome of spondyloarthropathy with infliximab]. Głowska A; Wiland P; Szechiński J Pol Arch Med Wewn; 2005 Jan; 113(1):42-7. PubMed ID: 16130600 [TBL] [Abstract][Full Text] [Related]
25. The Seronegative Spondyloarthropathies. Duba AS; Mathew SD Prim Care; 2018 Jun; 45(2):271-287. PubMed ID: 29759124 [TBL] [Abstract][Full Text] [Related]
26. [Spondylarthropathies and anti-TNFalpha drugs]. Pavy S; Allanore Y; Kahan A Rev Med Interne; 2005 Sep; 26(9):717-24. PubMed ID: 16154026 [TBL] [Abstract][Full Text] [Related]
27. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom. Nisar MK; Rafiq A; Östör AJ Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501 [TBL] [Abstract][Full Text] [Related]
28. Management of spondyloarthropathy: new pharmacological treatment options. Lee RZ; Veale DJ Drugs; 2002; 62(16):2349-59. PubMed ID: 12396227 [TBL] [Abstract][Full Text] [Related]
29. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
31. Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis. Weiss PF; Fuhlbrigge RC; von Scheven E; Lovell DJ; Colbert RA; Brunner HI; Arthritis Care Res (Hoboken); 2022 Jul; 74(7):1058-1064. PubMed ID: 33278336 [TBL] [Abstract][Full Text] [Related]
32. Juvenile spondyloarthropathies: clinical manifestations and medical imaging. Azouz EM; Duffy CM Skeletal Radiol; 1995 Aug; 24(6):399-408. PubMed ID: 7481895 [TBL] [Abstract][Full Text] [Related]
33. Ocular features of the HLA-B27-positive seronegative spondyloarthropathies. Jhaj G; Kopplin LJ Curr Opin Ophthalmol; 2018 Nov; 29(6):552-557. PubMed ID: 30148724 [TBL] [Abstract][Full Text] [Related]
34. Etanercept in spondyloarthropathies. Part I: current evidence of efficacy. Palazzi C; D'Angelo S; Cantini F; Lubrano E; Marchesoni A; Mathieu A; Salvarani C; Scarpa R; Spadaro A; Olivieri I Clin Exp Rheumatol; 2011; 29(5):858-64. PubMed ID: 22041180 [TBL] [Abstract][Full Text] [Related]
35. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy? Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554 [TBL] [Abstract][Full Text] [Related]
36. Expanding the armamentarium for the spondyloarthropathies. Peloso PM; Braun J Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S36-43. PubMed ID: 15228620 [TBL] [Abstract][Full Text] [Related]
37. Patterns of biologic agent use in older males with inflammatory diseases: an institution-focused, observational post-marketing study. Tran S; Hooker RS; Cipher DJ; Reimold A Drugs Aging; 2009; 26(7):607-15. PubMed ID: 19655827 [TBL] [Abstract][Full Text] [Related]
38. Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis. Ungprasert P; Thongprayoon C; Davis JM Clin Rheumatol; 2016 Jul; 35(7):1795-803. PubMed ID: 26852316 [TBL] [Abstract][Full Text] [Related]
39. Biologic therapies in the spondyloarthritis: new opportunities, new challenges. Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466 [TBL] [Abstract][Full Text] [Related]